Skip to main content
March 22, 2024 @ 9:24 AM
NYSE:BMY

Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, and delivers innovative medicines for patients with serious diseases. They focus on areas such as oncology, immunology, cardiovascular disease, and fibrosis.

In terms of technical analysis, the stock of Bristol-Myers Squibb Company has recently broken to new lows. This indicates that the stock price has fallen below previous support levels and is reaching new price levels not seen before. The break to new lows suggests a bearish sentiment and potential further downside.

Traders and investors should exercise caution when considering buying or holding Bristol-Myers Squibb Company shares and closely monitor the stock's price action and market conditions.

Recent Posts

Technical Analysis of Gap Inc.

June 5, 2024 @ 10:25 AM
NYSE:GPS

Gap Inc. is a leading global retailer that offers clothing, accessories, and personal care products for men, women, and children. With a portfolio of well-known brands including Gap, Old Navy, Banana Republic, and Athleta, Gap Inc.

Technical Analysis of HP Inc.

June 5, 2024 @ 10:21 AM
NYSE:HPQ

HP Inc. is a leading technology company that specializes in providing a wide range of products and solutions for personal computing, printing, and imaging. With a strong presence in the global market, HP Inc.